Dr. Nader H. Moniri
Associate Dean for Research and Professor of Pharmaceutical Sciences
Education
- B.S., Biological Sciences, Georgia State University
- Ph.D., Pharmaceutical Sciences, University of North Carolina at Chapel Hill
- Postdoctoral Fellow, Pharmacology, Duke University Medical Center
Research Background and Interests
Dr. Moniri specializes in molecular pharmacology, signal transduction of G protein-coupled receptors (GPCRs) and the development of novel agents that modulate GPCR function.
His current research centers on signal transduction, alternative signaling, and the design of functionally selective modulators for the beta-2-adrenergic receptor. Dr. Moniri aims to characterize the mechanisms behind beta-2-adrenergic receptor-mediated generation of intracellular reactive oxygen species, which recent findings suggest are crucial for receptor function.
Dr. Moniri’s laboratory also studies neuro-endocrine GPCRs involved in glucagon/insulin balance, food intake, and satiety, and is developing new anti-diabetic agents targeting these receptors.
Courses
- PHA329 Pharmacy Fundamentals
- PHA467 Endocrine Pharmacotherapy
- PHA468 Infectious Diseases Pharmacotherapy
- PHA547 Nervous System Pharmacotherapy
- PHA548/549 Project Development/Introduction to Research
- PHA537 Gastrointestinal & Musculoskeletal Pharmacotherapy
- PHA799 Thesis Research
- PHA899 Doctoral Research
Contact Dr. Nader H. Moniri
Moye Pharmacy and Health Sciences Center, #239
(678) 547-6246
moniri_nh@mercer.edu